This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Parathyroid Surgery Experts No Longer Performing One-Side Parathyroid Operation For Hyperparathyroidism

TAMPA, Fla., March 28, 2012 /PRNewswire/ -- Dr James Norman, MD and his partners at the Norman Parathyroid Center have published a landmark study in this week's Journal of the American College of Surgeons describing how the operation they developed and advocated for more than 19 years has significantly poorer long-term outcomes. The unilateral or "one-side" parathyroid surgical procedure to remove parathyroid tumors from patients suffering from hyperparathyroidism is a dramatic change from the large neck operation that it replaced. Dr Norman and his partners have published many articles touting the benefits of the smaller, one-side operation, a procedure that has become the standard operation world-wide. Long-term followup, however, shows that many patients having a one-side operation will need another operation some years later to remove a second tumor.

"We changed parathyroid surgery forever in the mid 1990's by developing and advocating the use of technology to allow one-side neck operations to remove parathyroid tumors," said Norman. "We have performed over 17,500 parathyroid operations and unfortunately, quite a few patients who we believed were cured after a one-side operation began showing up with another parathyroid tumor between 3 and 15 years later. They obviously had a second smaller tumor that we did not see. In contrast, those patients in whom we examined all four parathyroid glands had a second tumor removed 20% of the time and their long-term cure rates remain near 100%."

"We began noticing big differences in cure rates about 6 years ago and thus began our avoidance of one-side parathyroid surgery," stated Dr Douglas Politz, a co-author. "Fortunately for the patients, the new mini-parathyroid operation to look at all 4 glands (both sides) is actually smaller and faster than the one-side operation we developed 18 years ago using techniques we are teaching with videos online."

"This is a very significant change in surgical practice," stated Dr Lee Metchick, an endocrinologist in Central Florida. "If one parathyroid tumor is removed and a smaller, second tumor remains, the patient doesn't achieve the full benefits of the operation." 

The study was presented at the 2011 meeting of the American College of Surgeons and is published in this month's issue of their primary Journal: Norman J, Lopez J, Politz D. Abandoning Unilateral Parathyroidectomy: Why We Reversed Our Position After 15,000 Parathyroid Operations.  Journal  American College of Surgeons. 2012 Mar;214(3):260-9

About Norman Parathyroid Center.  Located in Tampa, Florida, The Norman Parathyroid Center is the world's leading facility for the diagnosis and treatment of diseases of the parathyroid glands and hyperparathyroidism. Parathyroid.com is recognized as the leading authority on hyperparathyroidism, an illness caused by parathyroid tumors located in the neck which affect one in 1000 people causing high blood calcium, osteoporosis, chronic fatigue, depression, and kidney stones, among other conditions.

Media Contact: Callie Williford, 813-972-0000

SOURCE Norman Parathyroid Center

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs